[Results of the clinical testing of a new coronary drug, Cormelian].
D000328:Adult; D001381:Azepines / Q000627:therapeutic use*; D002306:Cardiac Volume / Q000187:drug effects; D002986:Clinical Trials as Topic; D003326:Coronary Circulation / Q000187:drug effects; D003327:Coronary Disease / Q000188:drug therapy* / Q000503:physiopathology; D004109:Dilazep / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D004341:Drug Evaluation; D004562:Electrocardiography; D006261:Headache / Q000139:chemically induced; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D009325:Nausea / Q000139:chemically induced; D010101:Oxygen Consumption / Q000187:drug effects; D013610:Tachycardia / Q000139:chemically induced; D014839:Vomiting / Q000139:chemically induced
D001381:Azepines; D004109:Dilazep